| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/07/2002 | WO2002009649A2 Cell internalized peptide-drug conjugates |
| 02/07/2002 | WO2002009641A2 Promyostatin peptides and methods of using same |
| 02/07/2002 | WO2001083439A3 Novel $g(y) crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same. |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001051506A3 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides |
| 02/07/2002 | US20020016442 Hepatitis C inhibitor tri-peptides |
| 02/07/2002 | US20020016321 Novel tricyclic compounds for the inhibition of the ICE/ced-3 protease family of enzymes |
| 02/07/2002 | US20020016298 Facilitate secretion of growth hormone (GH) by the anterior pituitary. |
| 02/07/2002 | US20020016294 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 02/07/2002 | US20020016291 Cyclic peptides as potent and selective melanocortin-4 receptor antagonists |
| 02/07/2002 | US20020016288 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 02/07/2002 | US20020016285 Antitumor and/or antileukemic effects |
| 02/07/2002 | US20020015680 A compound, comprising: a targeting moiety and a chelator, wherein the targeting moiety is bound to the chelator, is a qinolone nonpeptide, and binds to a receptor that is upregulated during angiogenesis |
| 02/07/2002 | CA2417885A1 Cell internalized peptide-drug conjugates |
| 02/07/2002 | CA2416260A1 Promyostatin peptides and methods of using same |
| 02/06/2002 | EP1177208A1 Spray drying of thrombin inhibitors |
| 02/06/2002 | EP1177197A2 Polyamines and their use in therapy |
| 02/06/2002 | EP1177168A1 Caspase inhibitors and the use thereof |
| 02/06/2002 | CN1078886C Inhibitor of inhibiting generation of beta-amyloid |
| 02/05/2002 | US6344570 Substituted urea derivatives as cell adhesion inhibitors |
| 02/05/2002 | US6344562 Thiazole derivatives |
| 02/05/2002 | US6344450 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/05/2002 | US6344449 Headache and morphine dependence |
| 02/05/2002 | US6344439 Agents for promoting bone formation |
| 02/05/2002 | US6344318 A selex method determining three dimensional structure of nucleic acid ligands by identifying a ligand to a specific target and modifying the nucleotides with a monomer to allow the ligand to mimic the structure and bind the target |
| 02/05/2002 | CA2127284C Protein- and peptide-metal ion pharmaceutical applications |
| 01/31/2002 | WO2002008250A2 Ghrelin antagonists |
| 01/31/2002 | WO2002008248A1 Method for producing peptide derivative |
| 01/31/2002 | WO2002008247A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | WO2002008244A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002007770A2 Polymeric conjugates of antitumor agents |
| 01/31/2002 | WO2001062775A3 Novel antiarrhythmic peptides |
| 01/31/2002 | WO2001061017A3 Modified cytokines for use in cancer therapy |
| 01/31/2002 | WO2001060416A3 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 01/31/2002 | US20020013490 Artificial sweetener |
| 01/31/2002 | US20020013476 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 01/31/2002 | US20020013320 Use of growth hormone secretagogues to treat systemic lupus erythematosus and inflammatory bowel disease |
| 01/31/2002 | US20020013315 For therapy Alzheimer's disease |
| 01/31/2002 | US20020013278 Using an interleukin-1 beta converting enzyme inhibitor pro-drug to treat apoptosis-, interferon-gamma inducing factor or interferon-gamma inducing diseases; antiinflammatory and -proliferative agents; autoimmune/degenerative disesesdiseases |
| 01/31/2002 | US20020013277 Composition and methods to improve neural outcome |
| 01/31/2002 | US20020013276 Investigational compounds |
| 01/31/2002 | US20020012948 Metallopeptide combinatorial libraries and applications |
| 01/31/2002 | US20020012631 As imaging agents for the diagnosis of cardiovascular disorders such as thromboembolic disease or atherosclerosis, infectious disease and cancer |
| 01/31/2002 | CA2416643A1 Ghrelin antagonists |
| 01/31/2002 | CA2412787A1 Process for the preparation of 5-phenylpentanoyl-ala-argl-{2-[3-amino-2-oxopyrrolidin-1-yl]propionyl}-ala-arg-ala-4-aminophenylacetamide |
| 01/31/2002 | CA2410766A1 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2410682A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | CA2410562A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/30/2002 | EP1175442A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
| 01/30/2002 | EP1175405A1 LACTAM INHIBITORS OF FXa AND METHOD |
| 01/30/2002 | EP1084138B1 Method for preparing aspartyl cyclohexylalaninamide |
| 01/30/2002 | EP0904539A4 Inhibiting protein interactions |
| 01/30/2002 | EP0904284B1 6-substituted amino-4-oxa-1-azabicyclo[3.2.0]heptan-7-one derivatives as cysteine protease inhibitors |
| 01/30/2002 | EP0605462B1 New isosteric peptides |
| 01/30/2002 | EP0535155B1 Libraries of modified peptides with protease resistance |
| 01/30/2002 | CN1078480C Somatostatin binding peptide-metal chelate conjugates |
| 01/29/2002 | US6342531 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 01/29/2002 | US6342504 Peptides as antithrombins and anticoagulants |
| 01/29/2002 | US6342368 WD-40-derived peptides and uses thereof |
| 01/29/2002 | US6342221 Antibody conjugate compositions for selectively inhibiting VEGF |
| 01/29/2002 | US6342219 As anti-angiogenic and in tumor therapy |
| 01/24/2002 | WO2002006307A1 Reduced fk228 and use thereof |
| 01/24/2002 | WO2002006306A2 SUBSTRATES AND ASSAYS FOR β-SECRETASE ACTIVITY |
| 01/24/2002 | WO2002006292A1 Phosphate esters of bis-amino acid sulfonamides containing substituted benzyl amines |
| 01/24/2002 | WO2002006190A2 Crystalline and salt forms of an hiv protease inhibitor |
| 01/24/2002 | WO2000053614A8 Method for producing glyco-conjugates of 20(s)-camptothecin |
| 01/24/2002 | US20020010335 Process and intermediates for growth hormone secretagogues |
| 01/24/2002 | US20020010316 Thiazole derivatives |
| 01/24/2002 | US20020010315 Treatment or amelioration of symptoms of adult respiratory distress syndrome, septic shock, and multiple organ failure. |
| 01/24/2002 | US20020009752 Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof |
| 01/24/2002 | CA2410898A1 Substrates and assays for .beta.-secretase activity |
| 01/23/2002 | EP1174438A1 Novel cyclic tetrapeptide derivatives and use thereof as drugs |
| 01/23/2002 | EP1174437A1 Melanocyte-stimulating hormone inhibitors |
| 01/23/2002 | EP1173480A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof |
| 01/23/2002 | EP1173469A2 Adhesion modulatory peptides and methods for use |
| 01/23/2002 | EP1173468A1 Integrin receptor antagonists |
| 01/23/2002 | EP1173467A1 Chemokine-derived synthetic peptides |
| 01/23/2002 | EP1173454A1 Method for producing glyco-conjugates of 20(s)-camptothecin |
| 01/23/2002 | EP1173413A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 01/23/2002 | EP1173223A2 Conjugates as therapies for cancers and prostate diseases |
| 01/23/2002 | EP0787137B1 Process for the preparation of n-carboxyanhydride amino acids from n-(n'-nitrosocarbamoyl)amino acids |
| 01/23/2002 | EP0745093B1 New oligopeptides with affinity to opioid receptors |
| 01/23/2002 | EP0739903B1 Carbamoylmethylurea derivative |
| 01/23/2002 | EP0623144B1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 01/23/2002 | CN1332737A Thrombin inhibitors |
| 01/23/2002 | CN1332723A Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 01/23/2002 | CN1078204C Amino acid amide derivative and fungicidal use and production process thereof |
| 01/22/2002 | US6340709 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing |
| 01/22/2002 | CA2038848C Hydantoin derivatives |
| 01/17/2002 | WO2002004423A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/17/2002 | US20020007070 For inhibiting loss of blood platelets; inhibiting formation of blood platelet aggregates, fibrin, thrombus, and embolus; anticoagulants embedded in devices for blood collection, circulation, storage (catheters, dialysis machines); stents |
| 01/17/2002 | US20020006943 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 01/17/2002 | US20020006379 Diagnosis of tissue damage, cancer |
| 01/17/2002 | CA2413035A1 Thrombin inhibitors comprising an aminoisoquinoline group |
| 01/16/2002 | EP1172432A1 Perfume precursor compositions and method for expressing perfume components |
| 01/16/2002 | EP1171598A2 Peptides and the use thereof to control pests |